@prefix biolink: .
@prefix infores: .
@prefix np: .
@prefix npx: .
@prefix orcid: .
@prefix pav: .
@prefix prov: .
@prefix rdf: .
@prefix rdfs: .
@prefix sub: .
@prefix this: .
@prefix xsd: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo .
}
sub:assertion {
a biolink:ChemicalEntity;
rdfs:label "Amphetamine sulfate";
biolink:category biolink:ChemicalEntity .
a biolink:DiseaseOrPhenotypicFeature;
rdfs:label "Narcolepsy";
biolink:category biolink:DiseaseOrPhenotypicFeature .
sub:_1 a biolink:Association;
rdf:object ;
rdf:predicate biolink:treats;
rdf:subject ;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2022-10-27T17:04:06.208646"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0003-4727-9435;
prov:wasQuotedFrom "Amphetamine sulfate tablets, USP 5 mg and 10 mg are indicated for: Narcolepsy" .
biolink: pav:version "2.3.0" .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCTQs+mANCSHWhIW/YPio468UdGNHsPvADpjfaW8um/v2L4AoDIANginfoU65VNbPT5D0ADt1y0uFNne3VEMr9Y+I2HFaz6IKj+LdYMJk6VUf5WJoImRHIX6BZQwcUc22CbTBFYxvqvp3UmmHrCrhLIZjDSyutExK3tOTRoMDjGowIDAQAB";
npx:hasSignature "B/QQXDuICgvKSCBg2YgXrT6VvCfoHJv2ajpXQPPTfl6HWnHOkLDKu77IOHZsXFXieUzBxCvExkFZ4l/FLrOLJi3u/LfEi9nrZ7KnSiTBJ3dUOK7aHymR8YBPc8Oc71DKbixKGPA0At01RYkPJHTLB/AEfRTh2XK2o3eWS4fMRk0=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2022-10-27T17:04:06.208646"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0003-4727-9435 .
}